Gabapentin for Chronic Pelvic Pain in Women (GaPP2) A Multicentre, Randomised, Double-Blind, Placebo-Controlled Trial

Telma Regina Mariotto Zakka, Diego Toledo Reis Mendes
In: Jornal dos Comitês · 2021 · vol. 5(3) · doi:10.5935/2675-7133.20210037 · W3203227211
OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-16 ⓘ

This multicenter, randomized, double-blind trial investigated the efficacy of gabapentin compared to placebo for treating chronic pelvic pain in women.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

chronic_pelvic_pain

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-10-15T06:24:24.424788+00:00
License: CC0 · commercial use OK